Neuroimaging Findings in a Brain With Niemann-Pick Type C Disease

被引:28
作者
Huang, Jei-Yie [1 ]
Peng, Sing-Fung [2 ]
Yang, Chih-Chao [3 ]
Yen, Kuo-Yang [4 ,5 ]
Tzen, Kai-Yuan [1 ]
Yen, Ruoh-Fang [1 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan
[4] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan
[5] China Med Univ Hosp, PET Ctr, Taichung, Taiwan
关键词
glucose metabolism; Niemann-Pick type C disease; magnetic resonance imaging; positron emission tomography; NPC1;
D O I
10.1016/S0929-6646(11)60080-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Niemann-Pick type C disease (MPG) is a rare autosomal recessive lipid storage disorder caused by impaired cellular functions in processing and transporting low-density lipoprotein-cholesterol. In this report, we present magnetic resonance imaging (MRI), magnetic resonance spectrography (MRS) and 18-fluoro-2-deoxyglucose positron emission tomography (PET) imaging results for a 22-year-old male NPC patient. The patient's two MRI studies (at age 19 years and 22 years) demonstrated progressive changes of brain atrophy that were more prominent at the frontal lobes, and hyperintense signals in bilateral parietal-occipital periventricular white matter. MRS (at age 19 years) revealed no significant decrease in N-acetyl aspartate/choline ratio in the left frontal central white matter. PET (at age 22 years) showed significant bilateral hypometabolism in the prefrontal cortex and dorsomedial thalamus, and hypermetabolism in the parietal-occipital white matter, lenticular nucleus of the basal ganglia, cerebellum and pons. The imaging findings noted by MRI, MRS and 18-fluoro-2-deoxyglucose PET offered a possible supplementary explanation for the clinical neurological symptoms of this NPC patient.
引用
收藏
页码:537 / 542
页数:6
相关论文
共 24 条
[1]  
[Anonymous], 2002, The human brain: an introduction to its functional anatomy
[2]   Adult-onset Niemann-Pick type C disease: A clinical, neuroimaging, and molecular genetic study [J].
Battisti, C ;
Tarugi, P ;
Dotti, MT ;
De Stefano, N ;
Vattimo, A ;
Chierichetti, F ;
Calandra, S ;
Federico, A .
MOVEMENT DISORDERS, 2003, 18 (11) :1405-1409
[3]   NIEMANN-PICK DISEASE TYPE-C AND TYPE-D [J].
BRADY, RO ;
FILLINGKATZ, MR ;
BARTON, NW ;
PENTCHEV, PG .
NEUROLOGIC CLINICS, 1989, 7 (01) :75-88
[4]   Functional brain networks in DYT1 dystonia [J].
Eidelberg, D ;
Moeller, JR ;
Antonini, A ;
Kazumata, K ;
Nakamura, T ;
Dhawan, V ;
Spetsieris, P ;
deLeon, D ;
Bressman, SB ;
Fahn, S .
ANNALS OF NEUROLOGY, 1998, 44 (03) :303-312
[5]   CLINICAL SPECTRUM OF NIEMANN-PICK DISEASE TYPE-C [J].
FINK, JK ;
FILLINGKATZ, MR ;
SOKOL, J ;
COGAN, DG ;
PIKUS, A ;
SONIES, B ;
SOONG, B ;
PENTCHEV, PG ;
COMLY, ME ;
BRADY, RO ;
BARTON, NW .
NEUROLOGY, 1989, 39 (08) :1040-1049
[6]   NPC1 and NPC2 regulate cellular cholesterol homeostasis through generation of low density lipoprotein cholesterol-derived oxysterols [J].
Frolov, A ;
Zielinski, SE ;
Crowley, JR ;
Dudley-Rucker, N ;
Schaffer, JE ;
Ory, DS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (28) :25517-25525
[7]  
Fu L S, 1995, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, V36, P221
[8]   24 month-treatment with wmiglustat of three patients with Niemann-Pick disease type C: Follow up using brain spectroscopy [J].
Galanaud, Damien ;
Tourbah, Ayman ;
Lehericy, Stephane ;
Leveque, Nathalie ;
Heron, Benedicte ;
de Villemeur, Thierry Billette ;
Guffon, Nathalie ;
Feillet, Francois ;
Baumann, Nicole ;
Vanier, Marie T. ;
Sedel, Feredric .
MOLECULAR GENETICS AND METABOLISM, 2009, 96 (02) :55-58
[9]   Neurodegeneration in the Niemann-Pick C mouse: Glial involvement [J].
German, DC ;
Liang, CL ;
Song, T ;
Yazdani, U ;
Xie, C ;
Dietschy, JM .
NEUROSCIENCE, 2002, 109 (03) :437-450
[10]  
HULETTE CM, 1992, CLIN NEUROPATHOL, V11, P293